6th Tumor Models Immuno Oncology 2022

Temi della conferenza
Returning in an in-person capacity on January 25-27, the 6th Tumor Models for Immuno-Oncology Summit 2022 remains dedicated to the preclinical immuno-oncology community - and is the one and only definitive meeting focusing on disease modeling to empower you to:

Validate your preclinical hypothesis, especially on solid tumors' microenvironment and biology.
Increase your model utility and toolbox to recapitulate human physiology and immune response.

Professional congress organizer (PCO)
Hanson Wade

Annotazioni
Brochure: https://go.evvnt.com/915858-3?pid=4832

Speakers: Angus Sinclair, Senior Vice President ImmunoOncology, IGM Biosciences, Markus Vallaster, Executive Medical Director - Cell Therapies and Immuno-Oncology, AstraZeneca, and more.

https://go.evvnt.com/915858-0?pid=4832

Ms. Anita Kelemen